Hiroki Shimura
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroki Shimura.
Vitamins and Hormones Series | 1995
Leonard D. Kohn; Hiroki Shimura; Y Shimura; Akinari Hidaka; Cesidio Giuliani; Giorgio Napolitano; Masayuki Ohmori; Giovanna Laglia; Motoyasu Saji
This chapter has outlined the complex process required for thyroid growth and function. Both events are regulated by TSHR via a multiplicity of signals, with the aid of and requirement for a multiplicity of hormones that regulate the TSHR via receptor cross-talk: insulin, IGF-I, adrenergic receptors, and purinergic receptors. Cross-talk appears to regulate G-protein interactions or activities induced by TSH as well as TSHR gene expression. The TSHR structure and its mechanism of signal transduction is being rapidly unraveled in several laboratories, since the recent cloning of the receptor. In addition, the epitopes for autoantibodies against the receptor that can subvert the normal regulated synthesis and secretion of thyroid hormones, causing hyper- or hypofunction, have been defined. Studies of regulation of the TSHR minimal promotor have uncovered a better understanding of the mechanisms by which TSH regulates both growth and function of the thyroid cell. A key novel component of this phenomenon involves TSH AMP positive and negative regulation of the TSHR. Negative transcriptional regulation is a common feature of MHC class I genes in the thyroid. Subversion of negative regulation or too little negative regulation is suggested to result in autoimmune disease. Methimazole and iodide at autoregulatory levels may be important in reversing this process and returning thyroid function to normal. Their action appears to involve factors that react with the IREs on both the TSHR and the TG promoter. Too much negative regulation, as in the case of ras transformation, results in abnormal growth without function. TTF-1 is implicated as a critical autoregulatory component in both positive and negative regulation of the TSHR and appears to be the link between TSH, the TSHR, TSHR-mediated signals, TG and TPO biosynthesis, and thyroid hormone formation. Differentially regulated expression of the TSHR and TG by cAMP and insulin depend on differences in the specificity of the TTF-1 site, that is, the lack of Pax-8 interactions with the TSHR, and the IRE sites. Single-strand binding proteins will become important in determining how TSHR transcription is controlled mechanistically.
Molecular Endocrinology | 1994
Hiroki Shimura; Shoichiro Ikuyama; Y Shimura; Shioko Kimura; Motoyasu Saji; Leonard D. Kohn
Molecular Endocrinology | 1992
Shoichiro Ikuyama; Hans Helmut Niller; Hiroki Shimura; Takashi Akamizu; Leonard D. Kohn
International Reviews of Immunology | 1992
Leonard D. Kohn; Shinji Kosugi; Toshiaki Ban; Motoyasu Saji; Shoichiro Ikuyama; Cesidio Giuliani; Akinari Hidaka; Hiroki Shimura; Takashi Akamizu; Kazuo Tahara; John Moriarty; Bellur S. Prabhakar; Dinah S. Singer
Molecular Endocrinology | 1996
Masayuki Ohmori; Hiroki Shimura; Y Shimura; Leonard D. Kohn
Journal of Biological Chemistry | 1994
Y Shimura; Hiroki Shimura; Masayuki Ohmori; Shoichiro Ikuyama; Leonard D. Kohn
Molecular Endocrinology | 1995
Hiroki Shimura; Y Shimura; Masayuki Ohmori; Shoichiro Ikuyama; Leonard D. Kohn
Endocrinology | 1995
Masayuki Ohmori; Hiroki Shimura; Y Shimura; Shoichiro Ikuyama; Leonard D. Kohn
Journal of Biological Chemistry | 1993
Hiroki Shimura; Shoichiro Ikuyama; Y Shimura; Leonard D. Kohn
Molecular Endocrinology | 1996
Masayuki Ohmori; Masanori Ohta; Hiroki Shimura; Yoshie Shimurat; Koichi Suzuki; Leonard D. Kohn